Last reviewed · How we verify

NCT04958148

Salt and Gut Study

Status unknown EARLY_PHASE1 Last updated 12 July 2021
What this trial tests

EARLY_PHASE1 trial testing Salt pills in High Blood Pressure in 40 participants. Status unknown.

Timeline
18 December 2020
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorAugusta University
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment40
Start date18 December 2020
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Augusta University

Who can join

Adults 18 to 50, any sex, with High Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High sodium intake is a significant risk factor for hypertension. Recently, animal studies connect high sodium intake to the gut-immune axis and highlight the gut microbiome as a potential therapeutic target to counteract salt-sensitive conditions and hypertension. The objective of this project is to determine the effects of high salt intake on gut microbiota composition and gut intestine barrier integrity, leading to increased BP in humans. The investigators also hypothesize that high salt intake affects the gut microbiome in a sex-specific manner. In this pilot study, The investigators also test whether telehealth or in-person nutritional coaching help to decrease dietary sodium intake and improve diet quality

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for High Blood Pressure

Currently open trials in the same condition.

Other Augusta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04958148.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing